About William Reisacher
Form D filings for Intrommune Therapeutics from 2021 to 2024 list William Reisacher as director.
William Reisacher first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name William Reisacher in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Reisacher works with at each company, as listed on that company's latest Form D.
Intrommune Therapeutics, Inc. · Form D, Jan 22, 2024
EB
Erick Berglund
Director
HP
Hemanshu Pandya
Director
JR
Jonathan Rich
Director
MN
Michael Nelson
President and director